Inhibition of eicosanoid synthesis and potential therapeutic benefits of 'dual pathway inhibition'.
Lauritsen
K
K
Department of Medical Gastroenterology, Odense University Hospital, Denmark.
Laursen
L S
LS
Kjeldsen
J
J
Bukhave
K
K
Rask-Madsen
J
J
D000818:Animals; D001168:Arthritis / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D015777:Eicosanoids / Q000037:antagonists & inhibitors*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy; D016859:Lipoxygenase Inhibitors / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy
D016861:Cyclooxygenase Inhibitors; D015777:Eicosanoids; D016859:Lipoxygenase Inhibitors